Efficacy and safety of pantoprazole for stress-ulcer prophylaxis in critically ill patients: A systematic review and Meta-analysis of randomized controlled trials.
Rahul Falodia, Rabia Ramzan, Tahir Mehmood Khan et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated the efficacy and safety of pantoprazole for stress-ulcer prophylaxis in critically ill patients, including both adults and children. The analysis of seven randomized controlled trials (approximately 9127 patients) found that pantoprazole significantly reduced clinically important gastrointestinal bleeding (RR = 0.53; p = 0.03) without affecting overall mortality or increasing infection rates.
Key findings
- Pantoprazole reduced clinically important GI bleeding (RR = 0.53; p = 0.03).
- Overall mortality was not significantly affected (RR ≈ 0.99; p = 0.68).
- Infection rates, including VAP and C. difficile, were similar between pantoprazole and placebo groups.
Why it matters
The findings suggest that pantoprazole can be an effective option for preventing gastrointestinal bleeding in critically ill patients, which is a common complication in this population. Understanding its safety profile is crucial for clinicians managing these patients.